Jennifer Andonian, MPH, is Senior Infection Control Epidemiologist, Department of Hospital Epidemiology and Infection Control, Johns Hopkins Hospital, Baltimore, MD.
Kelsie E. Galusha, MSN, RN, is a Labor and Delivery Staff Nurse, Salem Health, Salem, OR.
Health Secur. 2019 Jan/Feb;17(1):69-73. doi: 10.1089/hs.2018.0104.
In response to the 2014 Ebola outbreak, the Office of the Assistant Secretary for Preparedness and Response (ASPR) funded the creation of 10 Regional Ebola and Other Special Pathogen Treatment Centers (RESPTCs) across the United States. These high-level isolation units are designed to provide care for patients infected with high-consequence pathogens, such as viral hemorrhagic fevers, in an environment that is safe for patients, staff, the hospital, and surrounding communities. This commentary describes the impact on infection prevention and preparedness that the Johns Hopkins biocontainment unit has on the hospital and health system beyond the unit itself. Training, research projects, and collaborative partnerships conducted by a high-level isolation unit team while the unit is not activated for patient care can enhance infection prevention, multidisciplinary training and innovation, personal protective equipment design and testing, clinical skills, and infection prevention beyond the isolation setting.
针对 2014 年的埃博拉疫情，准备和应对助理部长办公室（ASPR）在美国各地资助创建了 10 个区域埃博拉和其他特殊病原体治疗中心（RESPTC）。这些高级隔离单位旨在为感染高后果病原体（如病毒性出血热）的患者提供护理，其环境对患者、工作人员、医院和周围社区都是安全的。本评论描述了约翰霍普金斯生物隔离单位对医院和卫生系统的感染预防和准备工作的影响，超出了单位本身的影响。高级隔离单位团队在未因患者护理而激活单位时进行的培训、研究项目和合作伙伴关系，可以加强隔离环境之外的感染预防、多学科培训和创新、个人防护设备的设计和测试、临床技能和感染预防。
